Rubicon Organics ( (ROMJF) ) has released its Q3 earnings. Here is a breakdown of the information Rubicon Organics presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rubicon Organics Inc. is a leading Canadian company specializing in the cultivation and sale of organic certified, premium, and super-premium cannabis products. The company operates in the cannabis industry and is known for its vertically integrated model and strong national distribution.
In its latest earnings report for the third quarter of 2025, Rubicon Organics reported a net revenue of $15.6 million, marking a 16% increase compared to the same quarter the previous year. The year-to-date net revenue reached $43.0 million, representing a 25% increase year-over-year. The company also achieved an Adjusted EBITDA of $1.7 million for the quarter.
Key highlights from the report include the acquisition of a Health Canada license for the Cascadia Facility, which is expected to significantly boost production capacity and revenue in 2026. The company also secured a $3.0 million capital loan and a $1.0 million line of credit to support its growth initiatives. Rubicon Organics has successfully expanded its market presence, achieving notable national market shares in premium cannabis products and expanding its international reach.
Looking ahead, Rubicon Organics is poised for continued growth, with expectations of increased revenue and Adjusted EBITDA in 2025. The company is focused on leveraging its newly licensed Cascadia Facility and expanding its market presence both domestically and internationally, positioning itself for long-term success in the premium cannabis market.